Bayer Aspirin introduces Aspirina to U.S. market

Bayer Aspirin announced that Aspirina, a popular pain relief option in Mexico, is now available for purchase in the United States, bringing a well-known brand to the Hispanic community.

As the Hispanic population in the U.S. continues to grow, currently representing 19% of the population and projected to reach 28% by 2060, Bayer Aspirin recognizes the importance of connecting with this vibrant community.

“Many Hispanic communities still face inadequate access to health care and consumer goods. As the fastest-growing demographic group in the U.S., the Hispanic population presents a unique opportunity for Bayer,” said Mohamed Atef, global brand lead for Aspirin at Bayer.

“By adding Aspirina to the U.S. portfolio, which has a strong equity in LATAM, we are placing the consumer at the center of our strategy. Data shows that 70% of Hispanic consumers feel a strong connection to their country of origin, making it essential for brands to honor and reflect this sentiment.”

Many U.S. consumers of Hispanic origin grew up with Bayer’s Aspirina — their parents and grandparents relied on it, instilling trust and nostalgia for the brand. Due to those deep connections, Aspirina has a 99% awareness rate in Mexico, with 67% of consumers using it regularly.

Aspirina is now available at select Walmart and Walgreens stores.